Arch Dis Child 97:181 doi:10.1136/archdischild-2011-301385
  • PostScript
  • Letters

Use of paracetamol and ibuprofen in children in a tertiary care hospital: are we becoming complacent?

  1. Tom Connell1,3
  1. 1Department of General Medicine, Royal Children's Hospital, Parkville, Victoria, Australia
  2. 2Department of Clinical Pharmacology, The University of Melbourne, Melbourne, Victoria, Australia
  3. 3Department of Infectious Diseases, Royal Children's Hospital, Melbourne, Victoria, Australia
  1. Correspondence to Dr Kate McCloskey, Department of General Medicine, Royal Children's Hospital, Melbourne, Flemington Road, Parkville, Victoria 3052, Australia; katemccloskey{at}
  • Received 14 November 2011
  • Accepted 22 November 2011
  • Published Online First 15 December 2011

Given the concerns regarding the routine administration of antipyretics (paracetamol and ibuprofen) in hospitalised children with fever, we recently audited antipyretic prescribing practices at the Royal Children's Hospital Melbourne, Australia (RCH). In this regard, we read with interest the recent editorial by McIntyre on the use of antipyretics in children with fever1 that shares our concerns.

As highlighted by McIntyre, there is no evidence that reducing fever in a sick child confers any benefit in reducing mortality. On the contrary, current evidence suggests that reducing fever through the use of antipyretics may in fact adversely affect the outcome following infection.1 In addition, …

Free sample

This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of ADC.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Navigate This Article